Sernova Biotherapeutics Inc (FRA:PSH0)
0.0825
+0.0010 (1.23%)
At close: Jan 9, 2026
Sernova Biotherapeutics Statistics
Total Valuation
FRA:PSH0 has a market cap or net worth of EUR 30.20 million. The enterprise value is 32.99 million.
| Market Cap | 30.20M |
| Enterprise Value | 32.99M |
Important Dates
The last earnings date was Tuesday, December 23, 2025.
| Earnings Date | Dec 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 336.70M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +6.95% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 4.08% |
| Owned by Institutions (%) | 0.04% |
| Float | 322.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -1.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.39 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.90 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -226.48% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 62.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.22M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:PSH0 has paid 5,835 in taxes.
| Income Tax | 5,835 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -44.44% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.10 |
| Relative Strength Index (RSI) | 49.49 |
| Average Volume (20 Days) | 1,781 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.29M |
| Pretax Income | -9.73M |
| Net Income | -9.74M |
| EBITDA | -9.14M |
| EBIT | -9.29M |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 163,952 in cash and 2.95 million in debt, with a net cash position of -2.79 million.
| Cash & Cash Equivalents | 163,952 |
| Total Debt | 2.95M |
| Net Cash | -2.79M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -15.51M |
| Book Value Per Share | -0.05 |
| Working Capital | -15.02M |
Cash Flow
| Operating Cash Flow | -6.75M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:PSH0 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.95% |
| Shareholder Yield | -6.95% |
| Earnings Yield | -32.25% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |